Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace

Company Overview - Odyssey Health, Inc. is a medical technology company focused on life-saving medical solutions and aims to create, acquire, and accumulate distinct assets and technologies that provide meaningful medical solutions [6] - Odyssey Medical Devices, Inc. is a wholly owned subsidiary of Odyssey Health, Inc. [6] Product Announcement - Odyssey Health has signed a sub-licensing agreement for exclusive, worldwide rights to the BreastCheck®, a non-invasive test for breast abnormalities [1] - The BreastCheck® test can be performed at home in just 15 minutes, providing immediate results and serving as an effective first-line screening device [2][4] Market Context - The breast cancer diagnostics market is rapidly growing, currently valued in the low tens of billions of dollars, with forecasts to double or more over the next 8-10 years [3] - Early detection has significantly increased breast cancer survival rates, with an estimated 317,000 new cases of invasive breast cancer expected to be diagnosed in women in the U.S. this year [3][5] Technology and Regulatory Status - The technology behind BreastCheck® is FDA registered in the U.S. and also registered with relevant regulatory authorities in the European Union and the United Kingdom [2] - BreastCheck® is designed to be an adjunct to established procedures for breast disease detection, such as clinical breast examinations and mammography [4] Future Outlook - The company expects to begin commercialization and generate initial revenue from BreastCheck® in the near future, marking a transition from a development-stage to a revenue-generating medtech company [3]